TOR3A represses type I interferon production and limits viral clearance during respiratory syncytial virus infection

Read full text
Authors: Xiaoping Li, Zhengrong Chen, Mengyun Wu, Peijie Zhu, Guodong Qiao, Jiaoyang Li, Yunfei Ye, Jiamin Cai, Ying Zhou, Xiaoqiu Dai, Yufeng Wang, CanCheng Li
+12 more Jiaqi Huang, J. Zhou, Fei Xu, Chensheng Tan, Yu Shao, Xiu Gao, Jingjing Hu, Xuena Xu, Chunsheng Dong, Chuangli Hao, Yi Yang, Jinping Zhang
Cited by: 0

Abstract

Type I interferons (IFN-I) are essential for antiviral immunity, and precise regulation of IFN-I production is crucial to balance viral clearance and immunopathology. Here, we demonstrate that the interferon-stimulated gene TOR3A negatively regulates type I IFN signaling during respiratory syncytial virus (RSV) infection. TOR3A expression was upregulated in macrophages and RSV-infected patients, and its deficiency enhanced antiviral responses, leading to reduced viral load. Mechanistically, RSV infection induced TOR3A expression through the IFN-STAT1 pathway, which in turn suppressed IFN-I production. Furthermore, TOR3A recruited the E3 ubiquitin ligase STUB1 to mediate K48-linked ubiquitination and proteasomal degradation of RIG-I at lysine 146, thereby promoting RSV immune evasion. Our study identifies TOR3A as a novel suppressor of antiviral immunity and uncovers a mechanism by which RSV exploits host ISGs to dampen IFN-I responses, providing new insights into viral pathogenesis and potential therapeutic strategies.

Fields of Study & Subjects

interferon and immune responses Respiratory viral infections research Immune Response and Inflammation

Publication details

Journal / source
Emerging Microbes & Infections
Volume
15
Issue
1
Pages
2637961–2637961
Publication date
5 March 2026
Language
EN